Embracing a novel approach to sourcing, Clarins ventures beyond the concept of “field to plate” to pioneer “field to skin” with its recent acquisition of Domaine Sainte Colombe in France. This 115-hectare expanse is poised to serve as both a production and processing hub for plants, adhering to the principles of regenerative agriculture while doubling as a laboratory for botanical research.
Scheduled for initial cultivation in autumn 2024, with the first harvest earmarked for 2025/6, Clarins plans to cultivate approximately 50 species of trees and plants on the site. Among the varieties slated for growth are quince, almond, apricot, lavender, and lemon thyme. The company envisions the estate evolving into a primary source of organic raw materials integral to Clarins’ product formulations, with a targeted supply of one-third of the botanicals required for its products by 2030.
This strategic acquisition aligns with Clarins’ overarching vision of melding raw material traceability with premium quality, efficacious formulas, and sustained innovation in the realm of responsible beauty. Virginie Courtin, Managing Director of Clarins, lauds the move as a pivotal stride towards a vertically integrated, ethical, and sustainable supply chain.
Courtin asserts, “I am proud of this strategic advance towards an integrated, more vertical, ethical and sustainable supply. For 70 years, Clarins has harnessed the science of plants to develop ever more effective and innovative cosmetic formulas. The acquisition of the Domaine illustrates this approach of continued progress towards more excellence, safety and traceability, for all our clients.”
